Related references
Note: Only part of the references are listed.Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration
Katrin Fasler et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION An Expert Panel Consensus
Tien Yin Wong et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)
Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients' persistence
Ingo Volkmann et al.
BMC OPHTHALMOLOGY (2020)
Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register
Monica Lovestam Adrian et al.
ACTA OPHTHALMOLOGICA (2019)
Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study
Michele Augsburger et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
OUTCOMES OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR THREE OR MORE YEARS A Review of Current Outcomes
Vivian L. Qin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)
Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye
Toke Bek et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)
Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study
Katja Hatz et al.
ACTA OPHTHALMOLOGICA (2017)
Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes
Jamie K. Chew et al.
OPHTHALMOLOGICA (2017)
Prevalence of Age-Related Macular Degeneration in Europe
Johanna M. Colijn et al.
OPHTHALMOLOGY (2017)
Treatment for neovascular age-related macular degeneration in Sweden: outcomes at seven years in the Swedish Macula Register
Inger Westborg et al.
ACTA OPHTHALMOLOGICA (2017)
Switching from pro re nata to treat-and-extend regimen improves visual acuity in patients with neovascular age-related macular degeneration
Line Kvannli et al.
ACTA OPHTHALMOLOGICA (2017)
Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report
Nichole Joachim et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration
Katja Hatz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies
Sebastian Wolf et al.
OPHTHALMOLOGICA (2016)
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials
Maureen G. Maguire et al.
OPHTHALMOLOGY (2016)
Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration
Annette Rasmussen et al.
ACTA OPHTHALMOLOGICA (2015)
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
Aaron Y. Lee et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
The Neovascular Age-Related Macular Degeneration Database Report 2: Incidence, Management, and Visual Outcomes of Second Treated Eyes
Javier Zarranz-Ventura et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ninety-Six-Week Results of the VIEW Studies
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
Gui-shuang Ying et al.
OPHTHALMOLOGY (2013)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated in the MARINA and ANCHOR Trials
Irene A. Barbazetto et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
Ninel Z. Gregori et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration
Takashi Ueta et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
The natural history and prognosis of neovascular age-related macular degeneration
Tien Wong et al.
OPHTHALMOLOGY (2008)
Share Paper
